将基因组数据纳入肺癌的多变量风险模型。 - Suppr

Suppr

超能文献

Incorporating genomic data into multivariate risk models for lung cancer.

作者信息

Young Robert P, Hopkins Raewyn J

出版信息

Genet Med. 2013 Aug;15(8):667-8. doi: 10.1038/gim.2013.89.

DOI:10.1038/gim.2013.89

PMID:23912891

Abstract

摘要

相似文献

Incorporating genomic data into multivariate risk models for lung cancer.

Genet Med. 2013 Aug;15(8):667-8. doi: 10.1038/gim.2013.89.

Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14.

Public health implications from COGS and potential for risk stratification and screening.

Nat Genet. 2013 Apr;45(4):349-51. doi: 10.1038/ng.2582.

The impact of germline testing for hereditary cancer postdiagnosis.

Am J Manag Care. 2019 Aug;25(9 Spec No.):SP285-SP287.

Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots.

Can J Urol. 2016 Oct;23(5):8429.

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.

BMC Med Genomics. 2015 Oct 15;8:63. doi: 10.1186/s12920-015-0140-y.

Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer.

Swiss Med Wkly. 2021 Sep 13;151:w30038. doi: 10.4414/SMW.2021.w30038.

Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening.

Am J Hum Genet. 2011 May 13;88(5):548-65. doi: 10.1016/j.ajhg.2011.04.001. Epub 2011 Apr 28.

Prostate cancer genetic testing: NCCN familial high-risk assessment: breast/ovarian.

Can J Urol. 2019 Oct;26(5 Suppl 2):29-30.

Current and Future Applications Of Genetic Prostate Cancer Screening in the Urologic Clinic.

Urol Nurs. 2014 Nov-Dec;34(6):281-9, 311.

引用本文的文献

Common variants of pro-inflammatory gene IL1B and interactions with PPP1R13L and POLR1G in relation to lung cancer among Northeast Chinese.

Sci Rep. 2023 May 5;13(1):7352. doi: 10.1038/s41598-023-34069-z.

Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study.

Prev Med Rep. 2021 May 16;23:101397. doi: 10.1016/j.pmedr.2021.101397. eCollection 2021 Sep.

Multi-analyte assays and early detection of common cancers.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2165-S2167. doi: 10.21037/jtd.2018.06.58.

Chronic obstructive pulmonary disease (COPD) and lung cancer screening.

Transl Lung Cancer Res. 2018 Jun;7(3):347-360. doi: 10.21037/tlcr.2018.05.04.

Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial.

BMC Res Notes. 2017 Oct 23;10(1):507. doi: 10.1186/s13104-017-2831-2.

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.

Int J Oncol. 2016 Jul;49(1):361-70. doi: 10.3892/ijo.2016.3499. Epub 2016 Apr 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Incorporating genomic data into multivariate risk models for lung cancer.

作者信息

Young Robert P, Hopkins Raewyn J

出版信息

Genet Med. 2013 Aug;15(8):667-8. doi: 10.1038/gim.2013.89.

DOI:10.1038/gim.2013.89

PMID:23912891

Abstract

摘要

相似文献

Incorporating genomic data into multivariate risk models for lung cancer.

Genet Med. 2013 Aug;15(8):667-8. doi: 10.1038/gim.2013.89.

Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14.

Public health implications from COGS and potential for risk stratification and screening.

Nat Genet. 2013 Apr;45(4):349-51. doi: 10.1038/ng.2582.

The impact of germline testing for hereditary cancer postdiagnosis.

Am J Manag Care. 2019 Aug;25(9 Spec No.):SP285-SP287.

Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots.

Can J Urol. 2016 Oct;23(5):8429.

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.

BMC Med Genomics. 2015 Oct 15;8:63. doi: 10.1186/s12920-015-0140-y.

Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer.

Swiss Med Wkly. 2021 Sep 13;151:w30038. doi: 10.4414/SMW.2021.w30038.

Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening.

Am J Hum Genet. 2011 May 13;88(5):548-65. doi: 10.1016/j.ajhg.2011.04.001. Epub 2011 Apr 28.

Prostate cancer genetic testing: NCCN familial high-risk assessment: breast/ovarian.

Can J Urol. 2019 Oct;26(5 Suppl 2):29-30.

Current and Future Applications Of Genetic Prostate Cancer Screening in the Urologic Clinic.

Urol Nurs. 2014 Nov-Dec;34(6):281-9, 311.

引用本文的文献

Common variants of pro-inflammatory gene IL1B and interactions with PPP1R13L and POLR1G in relation to lung cancer among Northeast Chinese.

Sci Rep. 2023 May 5;13(1):7352. doi: 10.1038/s41598-023-34069-z.

Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study.

Prev Med Rep. 2021 May 16;23:101397. doi: 10.1016/j.pmedr.2021.101397. eCollection 2021 Sep.

Multi-analyte assays and early detection of common cancers.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2165-S2167. doi: 10.21037/jtd.2018.06.58.

Chronic obstructive pulmonary disease (COPD) and lung cancer screening.

Transl Lung Cancer Res. 2018 Jun;7(3):347-360. doi: 10.21037/tlcr.2018.05.04.

Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial.

BMC Res Notes. 2017 Oct 23;10(1):507. doi: 10.1186/s13104-017-2831-2.

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.

Int J Oncol. 2016 Jul;49(1):361-70. doi: 10.3892/ijo.2016.3499. Epub 2016 Apr 25.